SCHEMBL4906439

SCHEMBL4906439

OCCOCCOC12CCC(C1)C1CCCC12

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909910 0.91
SCHEMBL4901997 0.85
SCHEMBL7613359 0.77
SCHEMBL1405828 0.75
SCHEMBL642795 0.73
SCHEMBL31034406 0.71
SCHEMBL4173375 0.67
SCHEMBL4901995 0.67
SCHEMBL176168 0.60 MEN1 (0.48) MEN1KMT2A
SCHEMBL4459210 0.60 MEN1 (0.48) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3281933-B1 (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO LTD (JP) 2020-08-19 EP disclosed
US-10266476-B2 (Meth)acrylate manufacturing method TOAGOSEI CO., LTD. (JP) 2019-04-23 US disclosed
US-10065916-B2 Method for producing (meth)acrylate TOAGOSEI CO., LTD (JP) 2018-09-04 US disclosed
US-20180118658-A1 (METH)ACRYLATE MANUFACTURING METHOD TOAGOSEI CO., LTD. (JP) 2018-05-03 US disclosed
US-20180105483-A1 METHOD FOR PRODUCING (METH)ACRYLATE TOAGOSEI CO., LTD. (JP) 2018-04-19 US disclosed
EP-3281933-A1 (METH)ACRYLATE MANUFACTURING METHOD Toagosei Co., Ltd. (JP) 2018-02-14 EP disclosed
EP-3269700-A1 METHOD FOR PRODUCING (METH)ACRYLATE Toagosei Co., Ltd. (JP) 2018-01-17 EP disclosed
US-20080318075-A1 Photocurable Resin Composition HITACHI CHEMICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118658-A1 (METH)ACRYLATE MANUFACTURING METHOD MMAB, PAM, MAT2B MEN1 57/4885KMT2A 535/4885
US-10065916-B2 Method for producing (meth)acrylate MMAB, ADH5, ADH1A MEN1 459/4885KMT2A 297/4885
US-20180105483-A1 METHOD FOR PRODUCING (METH)ACRYLATE MMAB, ADH5, ADH1A MEN1 459/4885KMT2A 297/4885
US-10266476-B2 (Meth)acrylate manufacturing method MMAB, PAM, MAT2B MEN1 57/4885KMT2A 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.